Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Rutishauser

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Clinical Nutrition (Edinburgh, Scotland)|December 29, 2019
Nutritional risk screening (NRS 2002) is a strong and modifiable predictor risk score for short-term and long-term clinical outcomes: secondary analysis of a prospective randomised trialLara Hersberger, Laura Bargetzi, Annika Bargetzi, et al.
Plos One|April 5, 2023
Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST" (Taper Or Abrupt Steroid STop) multicenter trialMathis Komminoth, Marc Y Donath, Matthias Hepprich, et al.
Eclinicalmedicine|September 7, 2021
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01January Weiner, Phillip Suwalski, Manuel Holtgrewe, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Clinical Nutrition (Edinburgh, Scotland)|December 29, 2019
Nutritional risk screening (NRS 2002) is a strong and modifiable predictor risk score for short-term and long-term clinical outcomes: secondary analysis of a prospective randomised trialLara Hersberger, Laura Bargetzi, Annika Bargetzi, et al.
Plos One|April 5, 2023
Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST" (Taper Or Abrupt Steroid STop) multicenter trialMathis Komminoth, Marc Y Donath, Matthias Hepprich, et al.
Eclinicalmedicine|September 7, 2021
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01January Weiner, Phillip Suwalski, Manuel Holtgrewe, et al.
Pageof 7